ARK Innovation ETF vs Cardinal Health Inc — how do they compare? ARK Innovation ETF trades at $81.34, while Cardinal Health Inc trades at $240.57 (market cap $55.88B). The key difference: Cardinal Health Inc pays a 0.86% dividend while ARK Innovation ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, ARK Innovation ETF nearer its low. Which is the better fit depends on your goals.
| ARKK | CAH | |
|---|---|---|
52-Week High | $92.50 | $240.26 |
52-Week Low | $63.52 | $146.04 |
Market Cap | — | $55.88B |
Sector | — | Health |
Enterprise Value | — | $59.91B |
Dividend Yield | — | 0.86% |
Trailing returns across standard periods
Latest headlines on both assets
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →